Review article · 2023 · Open access

Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review

Anne-Sophie Michel, Paul Kamudoni, Alexia Marrel, Rocco Adiutori, C. Desvignes-Gleizes, Sally Lanar, Peter Schache, Erica Spies, Josephine Park

Frontiers in Medicine, 10, 1197529 · Published 20 June 2023 · DOI 10.3389/fmed.2023.1197529

Open PDFView at the publisherCite this paper

In brief

“Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review” is a 2023 review article by Anne-Sophie Michel and 8 co-authors, published in Frontiers in Medicine. OpenAlex counts 12 citations as of 22 November 2026, which puts it in the top 6% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Medicine.

Citations
12
Most cited in
2025 (6)
Field-weighted impact
0.54
References
38
Authors
9

Abstract

Objective: Including qualitative research in clinical trial design is an innovative approach to understanding patients' perspective and incorporate the patient's voice in all stages of drug development and evaluation. This review aims to explore current practices, lessons learned from the literature, as well as how qualitative interviews are considered by health authorities for marketing authorization and reimbursement. Methods: A targeted literature review of Medline and Embase databases was conducted in February 2022 to identify publications on qualitative methods embedded in clinical trial of pharmaceutical products. An additional search of guidelines and labeling claims of approved products regarding qualitative research was performed in various sources of grey literature. Results: From the 24 publications and nine documents reviewed, we identified the research questions addressed with qualitative methods during clinical trials (e.g., change in quality of life, symptoms assessment, treatment benefit), preferred data collection methods (e.g., interviews), and data collection points (e.g., baseline and exit interviews). Moreover, the data from labels and HTAs demonstrate that qualitative data can play an important role in approval processes. Conclusion: The use of in-trial interviews is still emerging and is not yet common practice. Although the industry, scientific community, regulatory agencies and HTAs are showing an increasing interest in the use of evidence generated via in-trial interviews, guidance from regulators and HTAs would be helpful. Developing new methods and technologies to address the common challenges for such interviews is key to progress.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Michel, A.-S., Kamudoni, P., Marrel, A., Adiutori, R., Desvignes-Gleizes, C., Lanar, S., Schache, P., Spies, E., & Park, J. (2023). Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review. Frontiers in Medicine, 10, 1197529. https://doi.org/10.3389/fmed.2023.1197529

MLA 9

Michel, Anne-Sophie, et al. “Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review.” Frontiers in Medicine, vol. 10, 2023, p. 1197529. https://doi.org/10.3389/fmed.2023.1197529.

Chicago

Michel, Anne-Sophie, Paul Kamudoni, Alexia Marrel, Rocco Adiutori, C. Desvignes-Gleizes, Sally Lanar, Peter Schache, Erica Spies, and Josephine Park. 2023. “Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review.” Frontiers in Medicine 10: 1197529. https://doi.org/10.3389/fmed.2023.1197529.

Harvard

Michel, A.-S. et al. (2023) ‘Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review’, Frontiers in Medicine, 10, p. 1197529. doi:10.3389/fmed.2023.1197529.

IEEE

A.-S. Michel et al., “Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review,” Frontiers in Medicine, vol. 10, p. 1197529, 2023, doi: 10.3389/fmed.2023.1197529.

BibTeX

@article{michel2023integrating,
  title     = {{Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review}},
  author    = {Michel, Anne-Sophie and Kamudoni, Paul and Marrel, Alexia and Adiutori, Rocco and Desvignes-Gleizes, C. and Lanar, Sally and Schache, Peter and Spies, Erica and Park, Josephine},
  journal   = {Frontiers in Medicine},
  year      = {2023},
  volume    = {10},
  pages     = {1197529},
  doi       = {10.3389/fmed.2023.1197529},
  url       = {https://doi.org/10.3389/fmed.2023.1197529}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202444
202566
202622

Its field-weighted citation impact is 0.54: it has been cited 0.54 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • qualitative interviews
  • drug development
  • clinical trial design
  • patient perspectives
  • product labeling
  • health technology assessment
  • drug approval
  • reimbursement

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Michel, A.-S., Kamudoni, P., Marrel, A., Adiutori, R., Desvignes-Gleizes, C., Lanar, S., Schache, P., Spies, E., & Park, J. (2023). Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review. Frontiers in Medicine, 10, 1197529. https://doi.org/10.3389/fmed.2023.1197529

How many times has this paper been cited?

12 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Anne-Sophie Michel, Paul Kamudoni, Alexia Marrel, Rocco Adiutori, C. Desvignes-Gleizes, Sally Lanar, Peter Schache, Erica Spies, Josephine Park.

What is the DOI of this paper?

10.3389/fmed.2023.1197529, permanently at https://doi.org/10.3389/fmed.2023.1197529. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.